The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Richard M. Hoffman

New Mexico VA Health Care System

Albuquerque

87108

USA

[email]@unm.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • New Mexico VA Health Care System, Albuquerque, 87108, USA. 2009 - 2011
  • Medicine Service, New Mexico VA Health Care System and Department of Medicine, University of New Mexico School of Medicine, Albuquerque, USA. 2006 - 2010
  • Department of Medicine, New Mexico VA Health Care System, 111GIM 1501 San Pedro Drive SE, Albuquerque, USA. 2002 - 2010
  • Medicine Service, Albuquerque Department of Veterans Affairs Medical Center, NM 87108, USA. 2000 - 2004
  • Department of Medicine, Albuquerque Veterans Affairs Medical Center, University of New Mexico, Albuquerque 87131, USA. 1999 - 2002
  • Albuquerque VA Medical Center, and University of New Mexico School of Medicine, USA. 1999

References

  1. A system-based intervention to improve colorectal cancer screening uptake. Hoffman, R.M., Steel, S.R., Yee, E.F., Massie, L., Schrader, R.M., Moffett, M.L., Murata, G.H. Am. J. Manag. Care (2011) [Pubmed]
  2. Barriers to colorectal cancer screening: physician and general population perspectives, New Mexico, 2006. Hoffman, R.M., Rhyne, R.L., Helitzer, D.L., Stone, S.N., Sussman, A.L., Bruggeman, E.E., Viera, R., Warner, T.D. Prev. Chronic. Dis (2011) [Pubmed]
  3. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Hoffman, R.M., Lewis, C.L., Pignone, M.P., Couper, M.P., Barry, M.J., Elmore, J.G., Levin, C.A., Van Hoewyk, J., Zikmund-Fisher, B.J. Med. Decis. Making (2010) [Pubmed]
  4. The cautionary tale of PSA testing. Hoffman, R.M., Zeliadt, S.B. Arch. Intern. Med. (2010) [Pubmed]
  5. Randomized trial results did not resolve controversies surrounding prostate cancer screening. Hoffman, R.M. Curr. Opin. Urol (2010) [Pubmed]
  6. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Hoffman, R.M., Couper, M.P., Zikmund-Fisher, B.J., Levin, C.A., McNaughton-Collins, M., Helitzer, D.L., VanHoewyk, J., Barry, M.J. Arch. Intern. Med. (2009) [Pubmed]
  7. Prostate cancer testing following a negative prostate biopsy: over testing the elderly. Hoffman, R.M., Denberg, T., Hunt, W.C., Hamilton, A.S. J. Gen. Intern. Med (2007) [Pubmed]
  8. Microwave thermotherapy for benign prostatic hyperplasia. Hoffman, R.M., Monga, M., Elliot, S.P., Macdonald, R., Wilt, T.J. Cochrane. Database. Syst. Rev (2007) [Pubmed]
  9. Viewpoint: limiting prostate cancer screening. Hoffman, R.M. Ann. Intern. Med. (2006) [Pubmed]
  10. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Hoffman, R.M., Barry, M.J., Stanford, J.L., Hamilton, A.S., Hunt, W.C., Collins, M.M. Am. J. Med. (2006) [Pubmed]
  11. New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies. Hoffman, R.M., Stone, S.N., Herman, C., Jung, A.M., Cotner, J., Espey, D., Kozoll, R., Gavin, M.W. Prev. Chronic. Dis (2005) [Pubmed]
  12. Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. Hoffman, R.M., Stone, S.N., Espey, D., Potosky, A.L. BMC. Cancer (2005) [Pubmed]
  13. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls. Hoffman, R.M., Gilliland, F.D., Penson, D.F., Stone, S.N., Hunt, W.C., Potosky, A.L. Cancer (2004) [Pubmed]
  14. Misclassifying the indications for prostate-specific antigen testing may bias case-control studies of the efficacy of prostate cancer screening. Hoffman, R.M., Adams-Cameron, M.L., Murata, G.H. J. Clin. Epidemiol (2004) [Pubmed]
  15. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. Hoffman, R.M., MacDonald, R., Monga, M., Wilt, T.J. BJU Int. (2004) [Pubmed]
  16. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Hoffman, R.M., Hunt, W.C., Gilliland, F.D., Stephenson, R.A., Potosky, A.L. Cancer (2003) [Pubmed]
  17. Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Hoffman, R.M., Stone, S.N., Hunt, W.C., Key, C.R., Gilliland, F.D. Ann. Epidemiol (2003) [Pubmed]
  18. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. Hoffman, R.M., Harlan, L.C., Klabunde, C.N., Gilliland, F.D., Stephenson, R.A., Hunt, W.C., Potosky, A.L. J. Gen. Intern. Med (2003) [Pubmed]
  19. Using multiple cutpoints for the free-to-total prostate specific antigen ratio improves the accuracy of prostate cancer detection. Hoffman, R.M., Clanon, D.L., Chavez, M., Peirce, J.C. Prostate (2002) [Pubmed]
  20. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study. Hoffman, R.M., Shah, J.H., Wendel, C.S., Duckworth, W.C., Adam, K.D., Bokhari, S.U., Dalton, C., Murata, G.H. Diabetes. Care (2002) [Pubmed]
  21. Prostate-specific antigen testing accuracy in community practice. Hoffman, R.M., Gilliland, F.D., Adams-Cameron, M., Hunt, W.C., Key, C.R. BMC. Fam. Pract (2002) [Pubmed]
  22. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. Hoffman, R.M., Gilliland, F.D., Eley, J.W., Harlan, L.C., Stephenson, R.A., Stanford, J.L., Albertson, P.C., Hamilton, A.S., Hunt, W.C., Potosky, A.L. J. Natl. Cancer Inst. (2001) [Pubmed]
  23. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. Hoffman, R.M., Clanon, D.L., Littenberg, B., Frank, J.J., Peirce, J.C. J. Gen. Intern. Med (2000) [Pubmed]
  24. Alpha-tocopherol supplementation for men with existing coronary artery disease: a feasibility study. Hoffman, R.M., Garewal, H.S. Prev. Med (1999) [Pubmed]
  25. A population-based survey of prostate cancer testing in New Mexico. Hoffman, R.M., Gilliland, F.D. J. Community. Health (1999) [Pubmed]
 
WikiGenes - Universities